Merit Medical Q4 revenue $324.5M up 10.6%; non-GAAP EPS $0.81; issues FY2024 guidance and 3-year targets

MERIT MEDICAL SYSTEMS INC

2023-FY EPS reported $1.62 revenue$1,257,366,000

Q4 revenue $324.5M, +10.6% YoY; constant currency organic revenue +8.3%.
GAAP EPS $0.47 (vs $0.58); non-GAAP EPS $0.81 (vs $0.79).
Non-GAAP operating margin 18.2%, up from 17.8% in Q4 2022.
Issued FY2024 financial guidance (details not provided in excerpts).
Three-year targets: revenue CAGR 5-7% organic; op margin 20-22% by 2026; FCF >=$400M cumulative.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

MERIT MEDICAL SYSTEMS INC reported Q4 2023 results: EPS 0.47.

Period: Q4 2023
EPS: 0.47
Result: reported results

Exact text from the filing

Q4 2023 reported revenue of $324.5 million, up 10.6% year-over-year

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

MERIT MEDICAL SYSTEMS INC reported Q4 2023 results: EPS 0.47.

Period: Q4 2023
EPS: 0.47
Result: reported results

Exact text from the filing

Q4 2023 GAAP EPS $0.47, compared to $0.58 in Q4 2022

View on SEC.gov

Browse all earnings releases →

MERIT MEDICAL SYSTEMS INC filing history →

Source: SEC EDGAR

accession 0000856982-24-000012

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.